- Home
- About
- Events
- Nanopore Days
- WYMM Tour: Bangalore, India
WYMM Tour: Bangalore, India
Friday, 25th April 2025, 09:30 - 17:15 IST - Bangalore, India (time subject to change)
Generate ultra-rich data for answers with impact.
Who says you can’t see it all? With a comprehensive view of structural variants and methylation, nanopore technology powers the bigger and bolder research questions you’ve always wanted to ask.
Join us on Friday, 25th April 2025, in Kodihalli, Bangalore to hear from local experts who are breaking new ground in human genomics, using nanopore technology.
What you're missing matters. Stay on top of what's next.
Aside from talks ranging from human genomics for rare disease, to sequencing for cancer research, the full-day agenda will include networking breaks, Q&A, product displays, and opportunities to engage with your peers and nanopore experts.
Please note that this is an in-person event.
There is no delegate fee for this event, but registration is required. Lunch and refreshments will be provided. Your place at this event will be confirmed via email from events@nanoporetech.com.
Register
Agenda
**10:00 am-17:25 pm IST | Agenda (subject to change) | Speaker |
---|---|---|
09:30 am-10:00 am | Registration/Breakfast | |
10:00 am-10:10 am | Welcome | Gordon Sanghera, Oxford Nanopore Technologies |
10:10 am-10:30 am | Introduction | Tonya McSherry, Oxford Nanopore Technologies |
10:30 am-11:00 am | Born too soon: The molecular underpinnings of preterm birth | Arindam Maitra, BRIC-National Institute of Biomedical Genomics |
11:00 am-11:15 am | Lightning Talk: Hybrid de novo genome assembly of Lady Amherst's pheasant | Kritika M. Garg, Ashoka University, India |
11:15 am-11:30 am | Lightning Talk | To follow |
11:30 am-12:00 pm | ONT Long-Read Genome Sequencing: A Game-Changer in Clinical Genetics Practice | Gautham Arunachal Udupi, National Institute of Mental Health and Neuro sciences, Bangalore |
12:00 pm-12:30 pm | Comprehensive characterisation of acute leukemias using Oxford Nanopore based transcriptome sequencing | Mayur Parihar, Tata Translational Cancer Research Center/Tata Medical Center |
12:30 pm-13:45 pm | Networking Lunch | |
13:45 pm-14:15 pm | Updates from Oxford Nanopore Technologies | Lakmal Jayasinghe, Oxford Nanopore Technologies |
14:15 pm-14:45 pm | Detection and genomic variant analysis of pathogens affecting dairy cattle by Oxford Nanopore sequencing | Dhanasekaran Shanmugam, CSIR National Chemical Laboratory, Pune |
14:45 pm-15:00 pm | Hybrid genome sequencing: applications in prokaryotes and eukaryotes | Gautam Das, miBiome Therapeutics LLP |
15:00 pm-15:15 pm | Pioneering microbiome-based wellness in India | Debojyoti Dhar, Leucine Rich Bio Pvt Ltd |
15:15 pm-15:45 pm | Utility of long-read sequencing in an acute healthcare setting | Vaz Gnanam, Credence Genomics Holdings Pte Ltd, Singapore |
15:45 pm-16:15 pm | Networking break | |
16:15 pm-16:45 pm | Footprints of genomics: strengthening the blueprint for future public health strategy | Rajesh Pandey, CSIR-IGIB, Delhi |
16:45 pm-17:15 pm | Structural Variants in Indian Populations | Divya Tej Sowpati, CSIR Centre for Cellular and Molecular Biology, Hyderabad |
17:15 pm-17:25 pm | Closing comments | Chandra Iyer, Deputy High Commissioner to Karnataka & Kerala, His Majesty’s Deputy Trade Commissioner to South Asia |
Speakers
)
Welcome
Gordon Sanghera, Oxford Nanopore Technologies
...
)
Introduction
Tonya McSherry, Oxford Nanopore Technologies
...
)
Born too soon: The molecular underpinnings of preterm birth
Arindam Maitra , Associate Director and a Professor, NIBMG, India
Dr Arindam Maitra is the Associate Director and a Professor in BRIC-National Institute of Biomedical...
)
Hybrid de novo genome assembly of Lady Amherst's pheasant
Kritika M. Garg, Ashoka University, India
Dr. Kritika M. Garg is a Ramalingaswami fellow at the Centre for Interdisciplinary Archaeology Resea...
)
ONT Long-Read Genome Sequencing: A Game-Changer in Clinical Genetics Practice
Gautham Arunachal Udupi, National Institute of Mental Health and Neuro Sciences (NIMHANS)
Over 12 years of experience in Clinical Genetics especially in Neurogenetics Over 75 publications wi...
)
Comprehensive characterisation of acute leukemias using Oxford Nanopore based transcriptome sequencing
Mayur Parihar, Tata Translational Cancer Research Center/Tata Medical Center
I am a Senior Consultant in Departments of Lab Haeamtology, Molecular Pathology and CYtogenetics. I ...
)
Updates from Oxford Nanopore Technologies
Lakmal Jayasinghe, Oxford Nanopore Technologies
...
)
Detection and genomic variant analysis of pathogens affecting dairy cattle by Oxford Nanopore sequencing
Dhanasekaran Shanmugam, CSIR National Chemical Laboratory, Pune
Dr. Dhanasekaran Shanmugam is currently chief scientist in CSIR National Chemical Laboratory, Pune, ...
)
Hybrid genome sequencing: applications in prokaryotes and eukaryotes
Gautam Das, miBiome Therapeutics LLP
Dr Gautam Das is the Co-Founder & Chief Executive Officer of a genomics company 'miBiome Therapeutic...
)
Pioneering microbiome-based wellness in India
Debojyoti Dhar, Leucine Rich Bio Pvt Ltd
Dr Debojyoti Dhar, PhD is the co-founder and Director of South Asia’s first microbiome company, Leuc...
)
Utility of long-read sequencing in an acute healthcare setting
Vaz Gnanam, Credence Genomics Holdings Pte Ltd, Singapore
I am a medical doctor by profession, with a specialization in bioinformatics. My entrepreneurial jou...
)
Footprints of genomics: strengthening the blueprint for future public health strategy
Rajesh Pandey, CSIR-Institute of Genomics and Integrative Biology (CSIR-IGIB), India
Dr. Rajesh Pandey, Principal Scientist and Group Leader at CSIR-IGIB, India, works on INtegrative GE...
)
Structural Variants in Indian Populations
Divya Tej Sowpati, CSIR Centre for Cellular and Molecular Biology, India
PhD in Biochemistry, 2012 from the Centre for DNA Fingerprinting and Diagnostics, Hyderabad, India W...
)
Closing comments
Chandru Iyer , Deputy High Commissioner to Karnataka and Kerala, His Majesty’s Deputy Trade Commissioner for South Asia (Investment)
...